Erythropoietin maintains ribavirin dose and sustained virologic response during HCV treatment.

被引:0
|
作者
Senkbeil, LE [1 ]
Moss, JG [1 ]
Gaglio, PJ [1 ]
Dove, LM [1 ]
Lobritto, SJ [1 ]
Jacobson, IM [1 ]
Brown, RS [1 ]
机构
[1] New York Presbyterian Hosp, New York, NY USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1213
引用
收藏
页码:744A / 744A
页数:1
相关论文
共 50 条
  • [32] Achievement of Sustained Virologic Response in HCV-Infection Treatment after Liver Transplantation.
    Yaroshenko, Ekaterina B.
    Kornilov, Maxim N.
    Moysyuk, Yan G.
    LIVER TRANSPLANTATION, 2013, 19 : S147 - S147
  • [33] Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2
    Sikuler, Emanuel
    Tur-Kaspa, Ran
    Shemer-Avni, Yonat
    Delgado, Jorge
    Zilberman, Doron
    Fich, Alexander
    Baruch, Yaacov
    Hyam, Eytan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (06) : 730 - 733
  • [34] Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment
    Satoshi Takakusagi
    Hitoshi Takagi
    Yuichi Yamazaki
    Takashi Kosone
    Shigeo Nagashima
    Masaharu Takahashi
    Kazumoto Murata
    Hiroaki Okamoto
    Clinical Journal of Gastroenterology, 2023, 16 : 206 - 215
  • [35] HCV genotype does not predict sustained virologic response to interferon plus ribavirin in chronic hepatitis C patients with advanced fibrosis
    Cheinquer, H
    Coelho-Borges, S
    Cheinquer, N
    Sander, G
    Rezende, V
    Hadlich, E
    Stifft, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 230 - 230
  • [36] Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment
    Takakusagi, Satoshi
    Takagi, Hitoshi
    Yamazaki, Yuichi
    Kosone, Takashi
    Nagashima, Shigeo
    Takahashi, Masaharu
    Murata, Kazumoto
    Okamoto, Hiroaki
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (02) : 206 - 215
  • [37] Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
    Colette Smit
    Joop Arends
    Lars Peters
    Antonella d’Arminio Montforte
    Francois Dabis
    Robert Zangerle
    George Daikos
    Christina Mussini
    Josep Mallolas
    Stephane de Wit
    Annelies Zinkernagel
    Jaime Cosin
    Genevieve Chene
    Dorthe Raben
    Jürgen Rockstroh
    BMC Infectious Diseases, 15
  • [38] Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin
    Conti, Fabio
    Vukotic, Ranka
    Lorenzini, Stefania
    Riili, Anna
    Cursaro, Carmela
    Scuteri, Alessandra
    Loggi, Elisabetta
    Galli, Silvia
    Furlini, Giuliano
    Bernardi, Mauro
    Andreone, Pietro
    ANNALS OF HEPATOLOGY, 2014, 13 (02) : 196 - 203
  • [39] Rapid Virologic Response Predicts Sustained Virologic Response in Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin Therapy
    Sarwar, Shahzad
    Iqbal, Masood
    McCormick, P. Aiden
    O'Farrelly, Cliona
    Hegarty, John E.
    GASTROENTEROLOGY, 2009, 136 (05) : A836 - A837
  • [40] Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
    Smit, Colette
    Smit, Colette
    Arends, Joop
    Peters, Lars
    d'Arminio, Antonella
    Dabis, Montforte Francois
    Zangerle, Robert
    Daikos, George
    Mussini, Christina
    Mallolas, Josep
    de Wit, Stephane
    Zinkernagel, Annelies
    Cosin, Jaime
    Chene, Genevieve
    Raben, Dorthe
    Rockstroh, Juergen
    BMC INFECTIOUS DISEASES, 2015, 15